Mandate

Vinge advises TA Associates together with Goodwin Procter in connection with acquisition

August 23, 2023 M&A

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

TA is a leading global private equity firm focused on scaling growth in profitable companies. Warburg Pincus is a leading global growth investor and an experienced partner to management teams seeking to build durable companies with sustainable value. Epassi Group is Europe’s leading digital solution for employee benefits, with a reach of nearly 13 million users, over 13 500 employers, and more than 59 000 service providers. Epassi is a market leader in the provision of digital employee benefits within the Nordics, Italy and the UK and has been awarded by the Financial Times as one of the fastest growing companies in Europe in 2022 and 2023.

Vinge's team consisted mainly of Sofie Nordgren, Niklas Törnell and Emil Sandgrim.

Full pressrelease 

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025